Area of research
Molecular Biology · Oncology
Research interest
Research interests include Gut microbiota and health, Colorectal Cancer Surgical Treatments, RNA modifications and cancer, and Inflammatory Bowel Disease.
Gut microbe alleviates stress-related cancer metastasis by oleic acid degradation.
Kynurenine mediates the chemotherapy-induced intestinal toxicity through modulation of gut microbiota.
Author Correction: Gut stem cell necroptosis by genome instability triggers bowel inflammation.
Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum.
Publisher Correction: Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum.
KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression
Novel Co-MOF-doped gelatin/agar intelligent film for beef freshness visual tracking based on the structural change of ZIF-67 under ammonia etching effect
Polydopamine coated MXene and cellulose nanocrystal as photothermal and reinforcing nanofiller for liquid crystal elastomer-based light-driven soft actuator
Exercise-induced Metabolite N-lactoyl-phenylalanine Ameliorates Colitis by Inhibiting M1 Macrophage Polarization via the Suppression of the NF-κB Signaling Pathway
Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome
KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression.
Preparation of highly functionalised biochar from hydrochloric acid activated bagasse for the efficient removal of metal ions
Interleukin-10 deficiency suppresses colorectal cancer metastasis by enriching gut Parabacteroides distasonis
Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer.
Dietary whey protein protects against Crohn's disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome.
Glutamic-pyruvic transaminase 1 deficiency-mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression.
STAT1 mediates the pro-inflammatory role of GBP5 in colitis.
Tumor-intrinsic TTLL12 drives resistance to cancer immunotherapy via modulating myeloid-derived suppressor cells.
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
IDDF2025-ABS-0167 Malassezia restricta accelerates colorectal cancer metastasis via epithelial-mesenchymal transition
A high-performance blood-based DNA methylation test for early detection of gastrointestinal cancers.
An ABCC1-based risk model is effective in the diagnosis of synchronous peritoneal metastasis in advanced colorectal cancer.
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.